InsidersTradesSigma
삼성바이오로직스: directors' dealings · South Korea · DART (FSS)
DART:company-b39df3KR·DART (FSS)Mcap 64159.3Bn€Healthcare
Explore the full insider trade history of 삼성바이오로직스, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 삼성바이오로직스 has recorded 1 public disclosures. Market capitalisation: €64,159.3bn. The latest transaction was reported on 5 March 2026 — Other. Among the most active insiders: 삼성바이오로직스. All data is openly available.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
1386000.00 €
Analyst consensus
24 analystsStrong buy
1650000.00 €Target 2170392.50 €(+57%)2613811.00 €
Income statement
Revenue4556.97 Bn€
Gross profit2516.64 Bn€55% margin
Net income1784.35 Bn€39.9% margin
Valuation
PER (forward)28.4x
Beta0.26
Balance sheet & cash
Market cap64159.26 Bn€
Total debt927.09 Bn€
Free Cash Flow772.73 Bn€
Debt / Equity12%
Profitability & ownership
% insiders74.4%
% institutions15.3%
Last declaration on 5 March 2026
Declarations0 total
No declarations found
0 of 0 declarations